Pharmaceutical

India is the largest provider of generic drugs globally. Indian pharmaceutical sector supplies over 50% of global demand for various vaccines, 40% of generic demand in the US and 25% of all medicine in the UK.

India enjoys an important position in the global pharmaceuticals sector. The country has a large pool of scientists and engineers with potential to steer the industry ahead to greater heights. Presently over 80% of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.

The Government of India has taken several steps to boost the sector:

• Production Linked Incentive (PLI) Scheme for pharmaceuticals with budgetary outlay of US$ 2 billion
• Promotion of Medical Device Parks (MDP) in different states
• Pharma Vision 2020 aimed at making India a major hub for end-to-end drug discovery
• National Policy on Medical Devices to promote domestic manufacturing
• Creation of Bulk Drug Parks to reduce import dependence
• Fast track approval mechanism for new facilities and products

India presents numerous opportunities for investment in the pharmaceutical sector including contract research and manufacturing, biotechnology, medical devices, vaccines, biosimilars, and active pharmaceutical ingredients (APIs).

With a strong manufacturing base, skilled workforce, competitive costs, and robust regulatory framework, India is an attractive destination for pharmaceutical investments.